Sa400 PYLORIC DISTENSIBILITY ON FLIP TESTING PREDICTS CLINICAL RESPONSE TO BOTULINUM TOXIN INJECTION AMONG PATIENTS WITH IDIOPATHIC GASTROPARESIS

2021 ◽  
Vol 160 (6) ◽  
pp. S-493
Author(s):  
Lester Tsai ◽  
Todd P. Coleman ◽  
David C. Kunkel
Keyword(s):  
Botulinum Toxin ◽  
Clinical Response ◽  
Botulinum Toxin Injection ◽  
Idiopathic Gastroparesis

Correlation between clinical response and injection quality in treatment of spasmodic dysphonia

1996 ◽  
Vol 110 (6) ◽  
pp. 551-553 ◽  
Author(s):  
A. K. Tewary
Keyword(s):  
Botulinum Toxin ◽  
Effective Treatment ◽  
Clinical Response ◽  
Botulinum Toxin Injection ◽  
Spasmodic Dysphonia ◽  
Placebo Trial

AbstractBotulinum toxin injection is an effective treatment for spasmodic dysphonia. There are ethical difficulties in performing a controlled placebo trial to assess the effectiveness of this treatment. This paper shows a significantly decreased clinical response following technically poor injections given to patients who respond well to good quality injections.

Persistent Diplopia in Visually Mature Patients. Is it Intractable or something else? A Review and Case Series

2017 ◽  
pp. 90-108
Keyword(s):  
Botulinum Toxin ◽  
Extraocular Muscle ◽  
Botulinum Toxin Injection ◽  
Case Series ◽  
Sensory Adaptation ◽  
Single Vision ◽  
Injection Treatment ◽  
Vision Therapy ◽  
Extraocular Muscle Surgery

Diplopia is described as being intractable when there is inability to both fuse the two images and suppress the second image. Intractable diplopia persists despite achieving ocular alignment using either prisms, lenses,vision therapy,extraocular muscle surgery, or botulinum toxin injection. Treatment usually resorts to occluding or fogging the patient’s nondominant eye. Often times, however, adults having other causative mechanisms for supposedly persistent diplopia are able to achieve comfortable single vision with treatment that either establishes fusion or reactivates a preexisting sensory adaptation. This case series reviews these other causes of diplopia.

scholarly journals Changes in Muscle Mass after Botulinum Toxin Injection in Children with Spastic Hemiplegic Cerebral Palsy

Toxins ◽  
2021 ◽  
Vol 13 (4) ◽  
pp. 278
Author(s):  
Dongwoo Lee ◽  
Jaewon Kim ◽  
Ja-Young Oh ◽  
Mi-Hyang Han ◽  
Da-Ye Kim ◽  
...  
Keyword(s):  
Cerebral Palsy ◽  
Botulinum Toxin ◽  
Lean Body Mass ◽  
Muscle Mass ◽  
Body Mass ◽  
Botulinum Toxin Injection ◽  
Dual Energy ◽  
X Ray ◽  
Hemiplegic Cerebral Palsy

We aimed to evaluate muscle mass changes after injection of botulinum toxin (BoNT) in children with spastic hemiplegic cerebral palsy (CP). Children aged between 2 and 12 years who were diagnosed with hemiplegic CP with spastic equinus foot were prospectively recruited and administered BoNT in the affected leg. Lean body mass (LBM) of both legs and total limbs was measured by dual-energy X-ray absorptiometry (DXA) preinjection and 4 and 12 weeks after injection. A total of 15 children were enrolled into the study. LBM of both legs and total limbs increased significantly over 12 weeks of growth. The ratio of LBM of the affected leg to total limbs and to the unaffected leg significantly reduced at 4 weeks after injection compared with preinjection but significantly increased at 12 weeks after injection compared with 4 weeks after injection. In conclusion, the muscle mass of the affected leg after BoNT injection in children with hemiplegic spastic CP decreased at 4 weeks after BoNT injection but significantly recovered after 12 weeks after injection.

Sign in / Sign up

Export Citation Format

Share Document